Genetic Studies of Sarcomere-based Cardiac Diseases
基于肌节的心脏病的遗传学研究
基本信息
- 批准号:9397642
- 负责人:
- 金额:$ 40.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-01 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdultAffectAgeAllelesBAG3 geneBenignBiological AssayBiophysicsC-terminalCardiac MyocytesCardiomyopathiesCellsClinicalCollectionDataDiagnosisDilated CardiomyopathyDiseaseDoxorubicinEmbryonic DevelopmentEnvironmental Risk FactorExhibitsExonsFiberFoundationsFutureGenesGeneticGenetic HeterogeneityGenetic IdentityGenetic studyGenomeHeart DiseasesHeart Function TestsHeterogeneityHumanHuman GeneticsIndividualKnowledgeLeadLengthModelingMusMutagenesisMutationMyofibrilsN-terminalPathogenesisPathogenicityPatientsPeptidesPhenotypePopulationProtein IsoformsProteinsRNA SplicingSarcomeresSiteSolidSplice-Site MutationTechnologyTestingTherapeuticTherapeutic EffectVariantZebrafishanoctamin 5basecohortconnectindisease phenotypeeffective therapyforward geneticsgenetic approachgenome editingknockout animalmutantnoveloutcome forecastresponsescreeningsegregationtargeted treatmenttherapeutic developmenttherapeutic targettitin 1trait
项目摘要
Dilated cardiomyopathy (DCM) is a disorder with genetic heterogeneity and variable phenotypes.
TITIN truncating variants (TTNtvs)- nonsense, frameshift, and essential splice site, has been found to be
the most common genetic factor for DCM. However, TTNtvs are also found in reference populations and it
remains unclear why pathogenic TTNtvs were mainly found in exons encoding A-band domains, while
TTNtvs in other exons such as those affecting the N-terminal Z-disc domain are likely benign. Moreover,
patients with the same TTN mutation can exhibit highly variable disease phenotypes, presumably because
of different genetic background in personal genomes. To address these two bottlenecks on TTN-based
DCM, we leveraged efficient zebrafish genetics. To fill the first knowledge gap on allelic heterogeneity, we
utilized genome-editing technology and generated more than 10 ttntvs affecting either Z-disc or A-band
exons in zebrafish. To fill the second knowledge gap on variable phenotypes, we established a novel
mutagenesis screening-based strategy and successfully identified 4 genetic modifiers for DOX-induced
cardiomyopathy. We premise that some of these modifiers and related therapies for DOX-induced
cardiomyopathy might also be applicable to TTN-based DCM. We propose to conduct comprehensive
genetic studies of these ttntvs and candidate genetic modifiers to elucidate mechanisms and to seek
therapeutic strategies for TTNtv-based DCM. In our specific Aim 1, we aim to define phenotypic traits for
ttn-based DCM, and to discern toxic peptide, exon usage and cronos hypotheses for allelic heterogeneity of
ttn-based DCM. In our specific Aim 2, we will elucidate novel functions of the short ttn-novex3 isoform, and
test the hypothesis that N-terminal ttntvs affecting the ttn-novex3 isoform are cardiomyopathy modifiers. In
our specific Aim 3, we will determine whether the 4 modifying mutants for DOX-induced cardiomyopathy
also exert similar modifying effects on ttn-based DCM, and which gene can be a therapeutic target.
Completion of the proposal will establish zebrafish as an efficient vertebrate model that facilitates the
prognosis, diagnosis and therapeutic development for cardiomyopathies including TTN-based DCM.
扩张型心肌病(DCM)是一种具有遗传异质性和表型多样性的疾病。
Titin截断变异体(TTNtvs)-无稽之谈、移码和基本剪接位点,已被发现是
DCM最常见的遗传因素。然而,在参考人群中也发现了TTNtv,它
目前尚不清楚为什么致病的TTNtv主要发现在编码A-带结构域的外显子中,而
其他外显子中的TTNtv可能是良性的,例如那些影响N-末端Z-Disc结构域的外显子。此外,
具有相同TTN突变的患者可以表现出高度可变的疾病表型,推测是因为
在个人基因组中具有不同的遗传背景。要解决基于TTN的这两个瓶颈
DCM,我们利用了高效的斑马鱼基因。为了填补关于等位基因异质性的第一个知识空白,我们
利用基因组编辑技术,产生了10多个影响Z-Disk或A-band的ttntv
斑马鱼的外显子。为了填补关于可变表型的第二个知识空白,我们建立了一个新的
基于诱变筛选的DOX诱变策略及其4种遗传修饰剂的成功鉴定
心肌病。我们假设这些改良剂和相关疗法中的一些对DOX诱导的
心肌病也可能适用于以TTN为基础的扩张型心肌病。我们建议进行全面的
对这些ttntv和候选遗传修饰物的遗传学研究以阐明机制并寻求
以TTNTV为基础的扩张型心肌病的治疗策略。在我们的具体目标1中,我们的目标是定义
基于TTN的DCM,以及识别毒肽、外显子使用和Cronos假设的等位基因异质性
基于TTN的DCM。在我们的具体目标2中,我们将阐明短ttn-novex3亚型的新功能,以及
验证影响ttn-novex3亚型的N-末端ttntv是心肌病修饰物的假设。在……里面
我们的具体目标3,我们将确定DOX诱导的心肌病的4个修饰突变体
对以ttn为基础的扩张型心肌病也有类似的修饰作用,哪个基因可以作为治疗的靶点。
该提案的完成将使斑马鱼成为一种高效的脊椎动物模型,从而促进
心肌病的预后、诊断和治疗进展,包括基于TTN的扩张型心肌病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiaolei Xu其他文献
Xiaolei Xu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiaolei Xu', 18)}}的其他基金
Discovering cardiomyopathy modifiers in TOR signaling via zebrafish genetics
通过斑马鱼遗传学发现 TOR 信号传导中的心肌病修饰因子
- 批准号:
8403956 - 财政年份:2011
- 资助金额:
$ 40.71万 - 项目类别:
Discovering cardiomyopathy modifiers and therapies via zebrafish genetics
通过斑马鱼遗传学发现心肌病调节剂和疗法
- 批准号:
10222749 - 财政年份:2011
- 资助金额:
$ 40.71万 - 项目类别:
Discovering cardiomyopathy modifiers via zebrafish genetics
通过斑马鱼遗传学发现心肌病修饰因子
- 批准号:
9254591 - 财政年份:2011
- 资助金额:
$ 40.71万 - 项目类别:
Discovering cardiomyopathy modifiers in TOR signaling via zebrafish genetics
通过斑马鱼遗传学发现 TOR 信号传导中的心肌病修饰因子
- 批准号:
8081575 - 财政年份:2011
- 资助金额:
$ 40.71万 - 项目类别:
Discovering cardiomyopathy modifiers in TOR signaling via zebrafish genetics
通过斑马鱼遗传学发现 TOR 信号传导中的心肌病修饰因子
- 批准号:
8249068 - 财政年份:2011
- 资助金额:
$ 40.71万 - 项目类别:
Discovering cardiomyopathy modifiers in TOR signaling via zebrafish genetics
通过斑马鱼遗传学发现 TOR 信号传导中的心肌病修饰因子
- 批准号:
8600987 - 财政年份:2011
- 资助金额:
$ 40.71万 - 项目类别:
Discovering cardiomyopathy modifiers and therapies via zebrafish genetics
通过斑马鱼遗传学发现心肌病调节剂和疗法
- 批准号:
10609443 - 财政年份:2011
- 资助金额:
$ 40.71万 - 项目类别:
Discovering cardiomyopathy modifiers via zebrafish genetics
通过斑马鱼遗传学发现心肌病修饰因子
- 批准号:
8968677 - 财政年份:2011
- 资助金额:
$ 40.71万 - 项目类别:
Discovering cardiomyopathy modifiers and therapies via zebrafish genetics
通过斑马鱼遗传学发现心肌病调节剂和疗法
- 批准号:
10397635 - 财政年份:2011
- 资助金额:
$ 40.71万 - 项目类别:
Genetic Studies of Sarcomere-based Cardiac Diseases
基于肌节的心脏病的遗传学研究
- 批准号:
7837512 - 财政年份:2009
- 资助金额:
$ 40.71万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 40.71万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 40.71万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 40.71万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 40.71万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 40.71万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 40.71万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 40.71万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 40.71万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 40.71万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 40.71万 - 项目类别:
Research Grant